In addition to the existing types of information, and in accordance with social and political requirements and the legal mandate (Art 67 TPO), following the entry into force of the revised Therapeutic Products Act the public will also be kept informed – as per Art. 14 para. 1 abis-quater TPA – of application submissions, application decisions, document protection, temporary authorisations, stricter warnings and authorisations.
Furthermore, interested professionals will be provided with a public report on the results of the assessment of authorisation applications for approved and rejected authorisation applications in the form of the SwissPAR (Swiss Public Assessment Report).